Afya Ltd

Afya Ltd. is a medical education group, which engages in the provision of an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs, and continuing medical education activities. It operates through Education Services; and Digital Content, Residency Preparatory and Specialization Programs segments. The Education Services segment provides educational services through undergraduate and graduate courses related to medicine, other health sciences, and other undergraduate programs. The Residency Preparatory and Specialization Programs segment offers digital and printed medical content services, including online courses for residency preparatory, medical and other than medical post-graduate specialization programs and mobile app subscription for digital medical content. The company was founded on March 22, 2019 and is headquartered in Nova Lima, Brazil.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Afya Ltd excels in Q2 2024 earnings, eyes growth opportunities

Afya Ltd delivered a robust performance in Q2 2024, marked by significant growth in key financial metrics, student base expansion, and strategic acquisitions.
The company's strengths lie in its strong financial position, updated guidance, operational insights, and engagement with analysts on critical industry topics.
Challenges include maintaining margins, integrating acquisitions, managing growth effectively, and adapting to potential regulatory shifts in the sector.
Opportunities for Afya include leveraging growth trends, strategic partnerships, innovation, and operational excellence to drive sustainable value creation and market leadership.

Afya Ltd reports strong Q3 earnings and eyes sustainable growth

Afya Ltd delivered a robust performance in Q3 2024, with notable revenue and EBITDA growth, demonstrating operational efficiency and financial resilience.
Despite facing challenges in a competitive landscape, the company's strategic acquisitions and focus on operational metrics provide a solid foundation for future growth.
With a strong balance sheet, improved margins, and a focus on sustainable expansion, Afya Ltd is well-positioned to capitalize on opportunities in the healthcare education sector.
Investors should monitor Afya Ltd's execution of growth strategies, operational performance, and ability to navigate challenges to assess its long-term value creation potential.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA) today announced the acquisition of 100% of the total share capital of iClinic, through its wholly-owned subsidiary Afya Participações S.A.

Afya Limited Announces iClinic’s Acquisition

NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA) today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) granted the authorization to operate the undergraduate medicine course in Santa Inês in the State of Maranhão, under Mais Médicos II program.

Afya Limited Announces Medical School Authorization – Santa Inês - MA.

Afya's (AFYA) CEO Virgilio Gibbon on Q2 2020 Results - Earnings Call Transcript

Surpassed 1H20 Guidance; Synergies and Maturation Driving Margin Expansion Surpassed 1H20 Guidance; Synergies and Maturation Driving Margin Expansion

Afya Limited Announces Second Quarter and First Half 2020 Financial Results

NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Aug.  27, 2020  (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA) today announced it entered into a purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Faculdade de Ensino Superior da Amazônia Reunida, or FESAR.

Afya Limited Announces Entering into of Purchase Agreement for the Acquisition of Faculdade de Ensino Superior da Amazônia Reunida

NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Aug.  20, 2020  (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA) today announced it entered into a purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Faculdade Ciências Médicas da Paraíba, or FCMPB.

Afya Limited Announces Entering into of Purchase Agreement for the Acquisition of Faculdade Ciências Médicas da Paraíba

NOVA LIMA, Brazil and MINAS GERAIS, Brazil, Aug.  03, 2020  (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report second quarter 2020 financial results for the period ended June 30, 2020, following the close of the market on Thursday, August 27, 2020.

Afya Limited to Report Second Quarter 2020 Financial Results on August 27

NOVA LIMA, Brazil, July  21, 2020  (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA) today announced the acquisition of 100% of the total share capital of PEBMED, through its wholly-owned subsidiary Afya Participações S.A.

Afya Limited Announces PEBMED’s Acquisition

Afya (AFYA) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Afya (AFYA) Looks Good: Stock Adds 5.3% in Session

Afya Limited (AFYA) CEO Virgilio Deloy Capobianco Gibbon on Q1 2020 Results - Earnings Call Transcript

Continuing Trend of Growth, Maintaining Strong and Consistent Results;  1H20 Guidance Reaffirmed; Solid Cash Position of R$ 1.3 billion Continuing Trend of Growth, Maintaining Strong and Consistent Results;  1H20 Guidance Reaffirmed; Solid Cash Position of R$ 1.3 billion

Afya Limited Announces First Quarter 2020 Financial Results

NOVA LIMA, Brazil, May  25, 2020  (GLOBE NEWSWIRE) -- We are proud to announce that last week AFYA released its 2019 Sustainability Report. The report highlights the Company’s commitment and progress on environmental, social, and governance (ESG) initiatives, ensuring that our major objective is sustained: empower students to transform Brazil leading education, healthcare and technology to the most needed regions.

Afya Limited Releases 2019 Sustainability Report

NOVA LIMA, Brazil, May  22, 2020  (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), in order to provide shareholders and the market an update regarding the development of the ongoing COVID-19 pandemic and its impact on business, announces the following:

Afya Limited Provides Business Update Relating to COVID-19 Outbreak

Afya went public in July 2019, raising $260 million in an IPO.

Afya Grows But Faces Brunt Of Pandemic In Brazil

NOVA LIMA, Brazil, May  05, 2020  (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA) in addition to the Press Release released by the Company on February 21, 2020, today announced the closing of its acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Centro Universitário São Lucas, or UniSL.

Afya Limited Announces Closing of the Acquisition of Centro Universitário São Lucas

NOVA LIMA, Brazil, April  13, 2020  (GLOBE NEWSWIRE) -- The leading medical education group in Brazil - based on number of medical school seats - Afya Limited (Nasdaq: AFYA) is committed to the safety and health of its students. Afya believes that Medicine classes and knowledge gain even more relevance during the COVID-19 pandemic, particularly due to the geographical distribution of its medical courses in Brazil; Almost 70% of Afya students are in the North and Northeast regions of the country.

Afya launches online solutions to help healthcare professionals during the Covid-19 pandemic

Afya Limited (AFYA) CEO Virgilio Gibbon on Q4 2019 Results - Earnings Call Transcript

Afya Limited - A Growing Brazilian Education Provider

NOVA LIMA, Brazil, March  18, 2020  (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today announced that it has hired Luis André Blanco, who has joined Afya effective as of today, and will assume the position of Chief Financial Officer effective as of April 20, 2020.

Afya Limited Announces Hiring of Future CFO

NOVA LIMA, Brazil, March  17, 2020  (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), in light of the recent developments of the Coronavirus (COVID-19) pandemic, informs shareholders and the market of the measures the company is taking to mitigate any potential impact to students and employees.

Afya Limited Provides  Business Update Relating to COVID-19 Outbreak

NOVA LIMA, Brasil, Feb.  21, 2020  (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA) announced it entered into a purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Centro Universitário São Lucas, or UniSL. Closing of the transaction is subject to customary conditions precedent and antitrust approvals.

Afya Limited Announces Entering into of Purchase Agreement for the Acquisition of Centro Universitário São Lucas

NOVA LIMA, Brasil, Feb.  11, 2020  (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today announced that it closed its follow-on public offering of 12,426,740 Class A common shares at a public offering price of $27.50 per share. Afya issued and sold 3,019,928 Class A common shares, and certain selling shareholders of Afya (the “Selling Shareholders”), including Crescera Educacional II Fundo de Investimento em Participações Multiestratégia (“Crescera”), sold 9,406,812 Class A common shares, pursuant to a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (“SEC”). Afya estimates the net proceeds to it from the offering to be approximately US$80.2 million, after deducting underwriting discounts and commissions (before expenses). Afya will not receive any proceeds from the sale of Class A common shares by the Selling Shareholders.

Afya Limited Announces Closing of Follow-on Offering of Class A Common Shares

NOVA LIMA, Brazil, Feb.  07, 2020  (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today announced the pricing of a follow-on public offering of 12,426,740 Class A common shares at a public offering price of $27.50 per share, consisting of 3,019,928 Class A common shares offered by Afya, and 9,406,812 Class A common shares offered by certain selling shareholders of Afya (the “Selling Shareholders”), including Crescera Educacional II Fundo de Investimento em Participações Multiestratégia (“Crescera”), pursuant to a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (“SEC”). The offering is expected to close on February 11, 2020. In addition, Afya and Crescera have granted the underwriters a 30-day option to purchase up to 1,864,010 additional Class A common shares at the public offering price, less underwriting discounts and commissions. Afya will not receive any proceeds from the sale of Class A common shares by the Selling Shareholders.

Afya Limited Announces Pricing of Follow-on Offering of Class A Common Shares

EverBank Financial

An insurance-shopping portal, a U.K. software company, and a Brazilian medical school operator all have potential for outsized returns.

3 'Top Small-Cap'  Stocks to Buy in February

NOVA LIMA, Brazil, Feb.  04, 2020  (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today announced that it has launched a proposed follow-on public offering of 11,521,740 Class A common shares, consisting of 3,019,928 Class A common shares offered by Afya, and 8,501,812 Class A common shares offered by certain selling shareholders of Afya (the “Selling Shareholders”), including Crescera Educacional II Fundo de Investimento em Participações Multiestratégia (“Crescera”), pursuant to a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (“SEC”). In addition, Afya and Crescera expect to grant the underwriters a 30-day option to purchase up to 1,728,260 additional Class A common shares at the public offering price, less underwriting discounts and commissions. Afya will not receive any proceeds from the sale of Class A common shares by the Selling Shareholders.

News for Afya Ltd Stock (AFYA)